Cosmetic neurology
Top Cited Papers
- 28 September 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Neurology
- Vol. 63 (6) , 968-974
- https://doi.org/10.1212/01.wnl.0000138438.88589.7c
Abstract
Advances in cognitive neuroscience and neuropharmacology are yielding exciting treatments for neurologic diseases. Many of these treatments are also likely to have uses for people without disease. Here, I review the ways in which medicine might make bodies and brains function better by modulating motor, cognitive, and affective systems. These potential "quality of life" interventions raise ethical concerns, some related to the individual and others related to society. Despite these concerns, I argue that major restraints on the development of cosmetic neurology are not likely. Neurologists and other clinicians are likely to encounter patient-consumers who view physicians as gatekeepers in their own pursuit of happiness.Keywords
This publication has 34 references indexed in Scilit:
- Neuropeptide systems as novel therapeutic targets for depression and anxiety disordersTrends in Pharmacological Sciences, 2003
- Pharmacokinetics/Pharmacodynamics of Recombinant Human Erythropoietins in Doping Control1Sports Medicine, 2003
- Drugs???for???Increasing???Oxygen???Transport and Their Potential Use in Doping1Sports Medicine, 2003
- 'Smart Drugs': do they work? Are they ethical? Will they be legal?Nature Reviews Neuroscience, 2002
- Emerging ethical issues in neuroscienceNature Neuroscience, 2002
- NMDA receptor pathways as drug targetsNature Neuroscience, 2002
- Methylphenidate treatmentPediatric Neurology, 2002
- A Double-Blind, Placebo-Controlled Study of the Use of Amphetamine in the Treatment of AphasiaStroke, 2001
- Amphetamine Paired With Physical Therapy Accelerates Motor Recovery After StrokeStroke, 1995
- Central analgesic effects of aspirin‐like drugsFundamental & Clinical Pharmacology, 1995